Determination of the presence of interleukin-6 in bile after orthotopic liver transplantation: Its role in the diagnosis of acute rejection

Annals of Surgery

Volumn 223, Issue 2, 1996, Pages 204-211

  Umeshita, Koji ^a   Monden, Morito ^a   Tono, Takeshi ^a   Hasuike, Yasunori ^a   Kanal, Toshio ^a   Gotoh, Mitsukazu ^a   Mori, Takesada ^a   Shaked, Abraham ^b   Busuttil, Ronald W ^b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; INTERLEUKIN 6; OKT 3; STEROID; TACROLIMUS;

ADULT; AGED; ARTICLE; BILE LEVEL; BILIARY CIRRHOSIS; BLOOD LEVEL; BUDD CHIARI SYNDROME; DIAGNOSTIC VALUE; DRUG BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT REJECTION; HEPATITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; TREATMENT INDICATION;

ACUTE DISEASE; ADULT; AGED; ANIMALS; BILE; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT REJECTION; HUMANS; INTERLEUKIN-6; LIVER; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE CARE; RATS;

EID: 0030043376     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199602000-00014     Document Type: Article

References (38)

1. Starzl TE, Iwatsuki S, van Thiel DH, et al. Evolution of liver transplantation. Hepatology 1982; 2:614-636.
2. Calne RY, ed. Liver Transplantation. 2nd ed. London: Grune & Stratton, 1987.
3. Busuttil RW, Colonna JO II, Hiatt JR, et al. The first 100 liver transplants at UCLA. Ann Surg 1987; 206:387-402.
4. Hirano T, Yasukawa K, Harada H, et al. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 1986; 324:73-76.
5. Kishimoto T, Hirano T. Molecular regulation of B lymphocyte response. Ann Rev Immunol 1988; 6:485-512.
6. Zilberstein A, Ruggieri R, Korn JH, Revel M. Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species, inducible by growth-stimulatory cytokines. EMBO J 1986; 5:2529-2537.
7. Ikebuchi K, Wong GG, Clark SC, et al. Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci USA 1987; 84:9035-9039.
8. 2/B-cell Stim- ulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 1987; 84:7251-7255.
9. Muraguchi A, Hirano T, Tang B, et al. The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J Exp Med 1988; 167:332-344.
10. 2 interferon) functions as a second signal for interleukin 2 production by mature murine T cells. Proc Natl Acad Sci USA 1987; 84:7629-7633.
11. Garman RD, Raulet DH. Characterization of a novel murine T cell-activating factor. J Immunol 1987; 138:1121-1129.
12. Lotz M, Jink F, Kabouridis P, et al. B cell stimulating factor 2/ interleukin 6 is a costimulant for human thymocytes and T lymphocytes. J Exp Med 1988; 167:1253-1258.
13. Takai Y, Wong GG, Clark SC, et al. B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes. J Immunol 1988; 140:508-512.
14. Okada M, Kitahara M, Kishimoto S, et al. IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells. J Immunol 1988; 141:1543-1549.
15. Renauld J-C, Vink A, Snick JV. Accessory signals in murine cytolytic T cell responses. Dual requirement for IL-1 and IL-6. J Immunol 1989; 143:1894-1898.
16. Tono T, Monden M, Yoshizaki K, et al. Biliary interleukin 6 levels as indicators of hepatic allograft rejection in rats. Transplantation 1992; 53:1195-1201.
17. Ray RA, Lewin KJ, Colonna J, et al. The role of liver biopsy in evaluating acute allograft dysfunction following liver transplantation: a clinical histologic correlation of 34 liver transplants. Hum Pathol 1988; 19:835-848.
18. Williams JW, Vera S, Peters TG, et al. Cholestatic jaundice after hepatic transplantation. A nonimmunologically mediated event. Am J Surg 1986; 151:65-70.
19. Shenkin A, Fraser WD, Series J, et al. The serum interleukin 6 response to elective surgery. Lymphokine Res 1989; 8:123-127.
20. Ohzato H, Yoshizaki K, Nishimoto N, et al. Interleukin-6 as a new indicator of the inflammatory status: detection of serum levels of interleukin-6 and C-reactive protein after surgery. Surgery 1992; 111:201-209.
21. Tilg H, Nordberg J, Vogel W, et al. Circulating serum levels of interleukin 6 and C-reactive protein after liver transplantation. Transplantation 1992; 54:142-146.
22. Waage A, Slupphaug G, Shalaby R. Glucocorticoids inhibit the production of IL-6 from monocytes, endothelial cells and fibroblasts. Eur J Immunol 1990; 20:2439-2443.
23. Vandenbroecke C, Caillat-Zucman S, Legendre C, et al. Differential in situ expression of cytokines in renal allograft rejection. Transplantation 1991; 51:602-609.
24. Martinez OM, Krams SM, Sterneck M, et al. Intragraft cytokine profile during human liver allograft rejection. Transplantation 1992; 53:449-456.
25. Hirano T, Kishimoto T. Interleukin-6. In: Sporn MB, Roberts AB, eds. Handbook of Experimental Pharmacology. Heidelberg, Germany: Springer-Verlag, 1990:633-665.
26. Kishimoto T. The biology of interleukin-6. Blood 1989; 74:1-10.
27. Horii Y, Muraguchi A, Suematsu S, et al. Regulation of BSF-2/IL-6 production by human mononuclear cells: macrophage-dependent synthesis of BSF-2/IL-6 by T cells. J Immunol 1988; 141:1529-1535.
28. Wong GG, Clark SC. Multiple actions of interleukin 6 within a cytokine network. Immunol Today 1988; 9:137-139.
29. Aarden LA, de Groot ER, Schaap OL, Lansdorp PM. Production of hybridoma growth factor by human monocytes. Eur J Immunol 1987; 17:1411-1416.
30. Sironi M, Breviario F, Proserpio P, et al. IL-1 stimulates IL-6 production in endothelial cells. J Immunol 1989; 142:549-553.
31. Jirik FR, Podor TJ, Hirano T, et al. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J Immunol 1989; 142:144-147.
32. Shalaby MR, Waage A, Espevik T. Cytokine regulation of interleukin 6 production by human endothelial cells. Cell Immunol 1989; 121:378-382.
33. Matsuzaki N, Saji F, Kameda T, et al. In vitro and in vivo production of interleukin-6 by fetal mononuclear cells. Clin Immunol Immunopathol 1990; 55:305-314.
34. Frei K, Leist TP, Meager A, et al. Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system dur- ing viral meningitis and encephalitis: evaluation in a murine model infection and in patients. J Exp Med 1988; 168:449-453.
35. Houssiau FA, Bukasa K, Sindic CJM, et al. Elevated levels of the 26K human hybridoma growth factor (interleukin 6) in cerebrospinal fluid of patients with acute infection of the central nervous system. Clin Exp Immunol 1988; 71:320-323.
36. Nishimoto N, Yoshizaki K, Eiraku N, et al. Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myelopathy/tropical spastic paraparesis. J Neurol Sci 1990; 97:183-193.
37. van Oers MH, van der Heyden AAPAM, Aarden LA. Interleukin 6 (IL-6) in serum and urine of renal transplant recipients. Clin Exp Immunol 1988; 71:314-319.
38. Yoshimura N, Oka T, Kahan BD. Sequential determinations of serum interleukin 6 levels as an immunodiagnostic tool to differentiate rejection from nephrotoxicity in renal allograft recipients. Transplantation 1991; 51:172-176.